Can Javier Milei’s radical libertarianism save Argentina?
Our interview explores his wild economic ideas—and his authoritarian streak
Argentina needs saving. Annual inflation is 113%. The peso’s black-market value against the dollar has fallen by half this year. After decades of economic mismanagement, mostly under Peronist administrations, Argentines are fed up with their venal and incompetent politicians. Their dismay has helped propel Javier Milei, a self-described libertarian and “anarcho-capitalist” who entered Congress only in 2021, to become the front-runner for the presidential election in October. Even by the standards of Argentine politics, he can sound eccentric: he is said to have hired a medium to consult Conan, his dead mastiff.
This article appeared in the Leaders section of the print edition under the headline “Javier Milei’s dangerous allure”
Leaders September 9th 2023
- The Gulf’s boundless ambition to change the world
- America’s Supreme Court should adopt new ethics standards
- Can Javier Milei’s radical libertarianism save Argentina?
- Heat pumps show how hard decarbonisation will be
- Wall Street is racing to manage your wealth. That is a good thing
- China’s Belt and Road Initiative will keep testing the West
From the September 9th 2023 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Leaders
Sir Keir Starmer should aim higher in his reset with the EU
And he needs to be clearer about what Britain wants
To make electricity cheaper and greener, connect the world’s grids
Less than 3% of the world’s power is internationally traded—a huge wasted opportunity
Chinese AI is catching up, posing a dilemma for Donald Trump
The success of DeepSeek and other Chinese modelmakers threatens America’s lead
America has an imperial presidency
And in Donald Trump, an imperialist president for the first time in over a century
Tariffs will harm America, not induce a manufacturing rebirth
Donald Trump’s pursuit of tariffs will make the world poorer—and America, too
How to improve clinical trials
Involving more participants can lead to new medical insights